SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-064377
Filing Date
2015-09-10
Accepted
2015-09-09 17:42:27
Documents
3
Period of Report
2015-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-19161_18k.htm 8-K 24628
2 EX-99.1 a15-19161_1ex99d1.htm EX-99.1 22507
3 GRAPHIC g191611mmi001.gif GRAPHIC 4600
  Complete submission text file 0001104659-15-064377.txt   54731
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 151099625
SIC: 2834 Pharmaceutical Preparations